Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
Theranostics|July 1, 2024
Trop2-targeted therapies in solid tumors: advances and future directionsXinlin Liu, Leina Ma, Jiyixuan Li, et al.Journal of Molecular Medicine (Berlin, Germany)|January 8, 2013
Oncolytic adenovirus co-expressing miRNA-34a and IL-24 induces superior antitumor activity in experimental tumor modelWenjia Lou, Qing Chen, Leina Ma, et al.Journal of Neuro-Oncology|July 19, 2025
CLOCK promotes proliferation of glioblastoma cells through acetylating PRPS1/2Juanjuan Liu, Zhaoyuan Meng, Runze Wang, et al.The Journal of Biological Chemistry|July 14, 2026
Conditional dependency of oncogenic KRAS in driving ketone body catabolism and pancreatic cancer growthRunze Wang, Xue Li, Tongxin Zhang, et al.Frontiers in Immunology|June 19, 2025
F-box proteins at the crossroads of ubiquitination and tumor immunity: regulatory networks and immunotherapy strategiesMingzheng Dai, Shimin Chen, Yuanjing Wang, et al.Cancer Letters|December 15, 2015
MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathwaysYanmin Xu, Ji Huang, Leina Ma, et al.Frontiers in Pharmacology|January 2, 2025
Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCCXue Li, Shimin Chen, Yuanyuan Shi, et al.Frontiers in Immunology|June 28, 2023
Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasionJichun Lin, Wenshuo Fang, Zhuo Xiang, et al.Cancer Letters|April 9, 2026
CD276 promotes CD36-mediated lipid metabolism and confers resistance to tyrosine kinase inhibitorsXiaojuan Huang, Leina Ma, Yangyang Lu, et al.Cancer Letters|August 2, 2011
MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrestYanmin Xu, Feng Xia, Leina Ma, et al.Pageof 6